Quantum Biopharma (QNTM) Interest Coverage Ratio (2019 - 2026)
Quantum Biopharma (QNTM) posted Interest Coverage Ratio of 129.79 for Q1 2026, down 497.23% sequentially from 32.67 in Q4 2025, and up 3.06% YoY from 125.94 in Q1 2025.
Quantum Biopharma (QNTM) Interest Coverage Ratio (2019 - 2026) Analysis & Trends
Quantum Biopharma has reported Interest Coverage Ratio for 8 years, with the latest figure at 129.79 in Q1 2026.
- Quarterly Interest Coverage Ratio rose 3.06% year-over-year to 129.79 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 93.68 (up 67.19% YoY) and the FY2025 annual result came in at 96.81, up 80.19% from the prior year.
- Interest Coverage Ratio eased to 129.79 in Q1 2026 per QNTM's latest filing, from 32.67 in the prior quarter.
- Over five years, Interest Coverage Ratio peaked at 8715.47 in Q3 2023 and troughed at 11275.19 in Q4 2023.
- A 5-year average of 681.39 and a median of 133.89 in 2025 frame the typical range for Interest Coverage Ratio.
- The sharpest annual moves came in 2023 and 2025: Interest Coverage Ratio slumped 1540.4% in 2023, then jumped 102.93% in 2025.
- Over 5 years, Interest Coverage Ratio stood at 288.03 in 2022, then tumbled by 4014.62% to 11275.19 in 2023, then surged by 90.11% to 1115.43 in 2024, then surged by 102.93% to 32.67 in 2025, then slumped by 497.23% to 129.79 in 2026.
- According to Business Quant data, Interest Coverage Ratio over the past three periods registered 129.79, 32.67, and 51.09 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.42 |
| 10 | Quantum Biopharma | 15.44 Mn | 11.80 Mn | - | -27.13 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -129.79 |
| Dec 31, 2025 | 32.67 |
| Sep 30, 2025 | -51.09 |
| Jun 30, 2025 | -41.50 |
| Mar 31, 2025 | -133.89 |
| Dec 31, 2024 | -1,115.43 |
| Sep 30, 2024 | -403.15 |
| Jun 30, 2024 | -413.62 |
| Mar 31, 2024 | -181.84 |
| Dec 31, 2023 | -11,275.19 |
| Sep 30, 2023 | 8,715.47 |
| Mar 31, 2023 | -4,148.75 |
| Mar 31, 2022 | 288.03 |
| Jun 30, 2021 | -670.79 |
| Mar 31, 2021 | 507.25 |
| Sep 30, 2020 | -215.74 |
| Jun 30, 2020 | -70.52 |
| Mar 31, 2020 | -68.74 |
| Dec 31, 2019 | -137.41 |
| Sep 30, 2019 | -115.99 |